Company Monitoring Page for Novartis

latest headlines for company on cafepharma

Omeros Prevails in Patent Dispute With Sandoz
CP Wire
Thu, 07/26/18 - 11:24 am
Tags:
Omeros, Sandoz, Novartis, patents, Omidria
Months after IPO, Novartis spinout resTORbio wins on PhIIb data — stock soars
Endpoints
Wed, 07/25/18 - 10:24 am
Tags:
ResTORbio, RTB101, Novartis
Kymriah Manufacturing Issues Spell Trouble for Commercialization of Novartis CAR-T Therapy
Xtalks
Mon, 07/23/18 - 10:40 pm
Tags:
Novartis, Kymriah, drug manufacturing, CAR-T, Cell for Cure
Roche has taken the Trump pledge, joining Pfizer, Novartis and Merck in promising to hold the line on drug prices
Endpoints
Fri, 07/20/18 - 09:47 am
Tags:
Roche, Merck, Pfizer, Novartis, drug pricing, Donald Trump
Trump thanks Novartis, Pfizer for not raising drug prices
Yahoo/Reuters
Thu, 07/19/18 - 10:00 am
Tags:
Donald Trump, drug pricing, Novartis, Pfizer
Novartis to Pay as Much as $1 Billion for Rights to Skin Drug
Yahoo/Bloomberg
Thu, 07/19/18 - 09:53 am
Tags:
Novartis, Galapagos, MorphoSys, MOR106, atopic dermatitis
Novartis' MS patent win also a win for Celgene's impending MS drug: analyst
Medical Marketing and Media
Wed, 07/18/18 - 10:49 pm
Tags:
Celgene, Novartis, ozanimod, Gilenya, MS, multiple sclerosis, patents
FDA Approves First Cancer Drug Under New Real Time Review Program
CP Wire
Wed, 07/18/18 - 01:39 pm
Tags:
FDA, Novartis, Kisqali, breast cancer, Scott Gottlieb, Real Time Oncology Review
Novartis Reports Growth in Q2 2018 Earnings
Market Realist
Wed, 07/18/18 - 12:19 pm
Tags:
Novartis, earnings
Under the gun for Cohen deal, Novartis CEO Vas Narasimhan hits the brakes on US drug price hikes
Endpoints
Wed, 07/18/18 - 09:30 am
Tags:
Novartis, Vas Narasimhan, drug pricing, Donald Trump, Michael Cohen
Is a Surprise in the Cards for Novartis in Q2 Earnings?
Yahoo/Zacks.com
Mon, 07/16/18 - 09:35 am
Tags:
Novartis, earnings
Novartis, Michael Cohen contacts were more extensive than previously disclosed
Stat
Fri, 07/13/18 - 12:00 pm
Tags:
Novartis, Joe Jimenez, Michael Cohen, Donald Trump
MS patent win boosts Novartis’ Gilenya, helps Celgene and maybe Biogen too
Fierce Pharma
Fri, 07/13/18 - 11:52 am
Tags:
patents, Novartis, MS, Gilenya, Celgene, exclusivity
Novartis partners with French CDMO to bolster CAR-T supply
Biopharma Dive
Thu, 07/12/18 - 10:40 pm
Tags:
Novartis, CAR-T, Cell for Cure, France
Pharmas call off price hikes after California law forces new warnings: report
Fierce Pharma
Wed, 07/11/18 - 11:15 pm
Tags:
drug pricing, California, Novo Nordisk, Roche, Novartis, Gilead Sciences
Novartis joins the Big Pharma exodus out of antibiotics, dumping research, cutting 140 and out-licensing programs
Endpoints
Wed, 07/11/18 - 10:57 pm
Tags:
Novartis, R&D, antibiotics, antivirals, layoffs
Novartis punts a late-stage PI3K drug with a worrying safety profile to one of China’s upstart biotechs
Endpoints
Wed, 07/11/18 - 10:20 am
Tags:
Novartis, buparlisib, China
Mylan launches generic drug-delivery patch for dementia patients
Drug Delivery Business News
Mon, 07/9/18 - 11:26 am
Tags:
Mylan, rivastigmine, generics, Novartis, Exelon, dementia, Alzheimer's disease, Parkinson's Disease
3 Best Biotech Acquisitions of 2018 (So Far)
Motley Fool
Thu, 07/5/18 - 09:57 am
Tags:
M&A, biotech, Celgene, Juno Therapeutics, Novartis, AveXis, Roche, Foundation Medicine
Amgen, Novartis 'overwhelmed' by early interest in migraine drug Aimovig: expert
Fierce Pharma
Wed, 07/4/18 - 10:01 am
Tags:
migraines, Amgen, Novartis, Aimovig

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.